Regeneron Chief Scientific Officer George Yancopoulos said on a conference call. The FDA can authorize emergency use of a drug before completing its review for a formal approval. Shares of Regeneron haberleri

" Regeneron Chief Scientific Officer George Yancopoulos said on a conference call. The FDA can authorize emergency use of a drug before completing its review for a formal approval. Shares of Regeneron" Arama Sonuçları